Standardization to support companies and protect consumers in the expanding BCI market
The growth in bio-sensing modalities, end effectors, applications, and the variety of potential user populations has necessitated a more interoperable ecosystem of neurotechnologies. Additionally, the potential deployment and commercialization of BCI-based solutions for human users require researchers, manufacturers, and regulatory agencies to ensure these devices meet well-defined safety and effectiveness criteria.
CHAIR
Pasquale Arpaia
Prof. Pasquale Arpaia
Director of CIRMIS
University of Naples Federico II
PANELISTS
Yuntao Yu (Chair of Brain-Computer Interfaces - ISO/IEC JTC 1/SC 43)
Mariska Vanstensel (President of the BCI Society)
Reinhold Scherer (Board member and Standards Committee member of the International BCI Society)
Nicola Moccaldi (Chair of CEI/TC 324 Brain Computer Interface - IT)
World's leading BCI manufacturers
- Aequilibria Health (MT)
- ANT Neuro (NL)
- Cephalgo (FR)
- g.tec (AT)
